 |
 |
 |
 |
 |
 |
 |
 |
 |
FEATURES >> Top 5 Biotech VC Deals of 2010
Solace Pharmaceuticals has closed its Cambridge, MA-based office following disappointing results from a Phase II trial of its pain treatment pill SLC022. The company was founded in 2006 and has so far raised $15 million in capital. Solace's four remaining full-time employees are based out the company's office in Canterbury, U.K. Report
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2010 FierceMarkets. All rights reserved. |
 |
SHARE
WITH: